UK markets closed
NIKKEI 225
32,791.80 +483.94 (+1.50%) HANG SENG
16,201.49 -132.88 (-0.81%) CRUDE OIL
71.40 +0.17 (+0.24%) GOLD FUTURES
1,997.60 -16.90 (-0.84%) DOW
36,404.93 +157.06 (+0.43%) Bitcoin GBP
32,740.09 -2,176.79 (-6.23%)
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 87.03 |
| Open | 87.52 |
| Bid | 87.96 x 1100 |
| Ask | 88.07 x 800 |
| Day's range | 85.61 - 88.10 |
| 52-week range | 55.25 - 159.89 |
| Volume | |
| Avg. volume | 1,557,790 |
| Market cap | 8.205B |
| Beta (5Y monthly) | 1.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.80 |
| Earnings date | 26 Feb 2024 - 01 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 140.28 |
Motley FoolCould Sarepta Therapeutics Stock Help You Become a Millionaire?
Sarepta Therapeutics (NASDAQ: SRPT) is a mid-cap stock that has the potential to be a big player in the gene therapy market -- at least, so the business and its investors hope. It has made for a volatile investment in recent years, but with a possible game-changing treatment in its portfolio, there may be a ton of upside for Sarepta in the long run. With over 40 programs currently in development, Sarepta is hopeful it can become a leading genetic medicine company one day.
ZacksWhy Is Myriad (MYGN) Up 3% Since Last Earnings Report?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksSarepta Therapeutics (SRPT) Up 4.5% Since Last Earnings Report: Can It Continue?
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2023 Yahoo. All rights reserved.